Nuron Biotech, Inc.

Nuron Biotech, Inc.

Nuron Biotech, Inc.

Date Founded



1 East Uwchlan Avenue,Suite 302,Exton, PA 19341

Type of Company


Employees (Worldwide)

11 - 50


Hospitals & Patient Services
Medical Support Services
Holding Companies

Company Description

Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA.

Contact Data
Trying to get in touch with decision makers at Nuron Biotech, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Director


Associate Director

Vice President-Regulatory Affairs

Business Advisor


Global Clinical Project Manager

Business Analyst

Board of Directors

Founder at Nuron Biotech, Inc.

Chief Financial & Accounting Officer at Spark Therapeutics, Inc.

Founder at Healthcare Royalty Management LLC

Partner at 1315 Capital LLC

President at Bhavnagar Industrial Gas Manufacturing Association

Paths to Nuron Biotech, Inc.
Potential Connections via
Relationship Science
Nuron Biotech, Inc.
Recent Transactions
Details Hidden

Nuron Biotech, Inc. raised money in a private placement transaction

Details Hidden

Nuron Biotech, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onNuron Biotech, Inc. raised money in a private placement transaction

Advisors & Consultants
Legal Advisor

Partner at Reed Smith LLP

Legal Advisor

Partner at Milbank LLP

Details Hidden

Healthcare Royalty Management invests primarily in commercial stage healthcare companies, pharmaceutical, biotechnology and products through the purchase of traditional passive royalties, the creation of synthetic royalties, structured debt and equity instruments. The firm focus on healthcare companies and products across a broad range of therapeutic areas predominately in the US and European Union. They targets investments of $20 million to $200 million. They provides financing capital to assist in the transfer of product and execution risk, finance new development opportunities, acquire new products or technologies, fund additional capital needs and monetize product royalties.

Details Hidden

Former Associate Director at Pfizer, Inc.

Details Hidden

Former Senior Director-Global Technology Transfer at Pfizer, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nuron Biotech, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nuron Biotech, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Nuron Biotech, Inc..